Michael Berman
Tel Aviv, Israel
Joined in 2004

Investing in innovation and guiding medical technology companies is the ultimate path to doing well and doing good.
A medical device entrepreneur, Mike works with a select group of high-potential, early-stage companies. As a consultant to RiverVest, Mike provides the firm with advice on existing and potential portfolio companies, especially as it relates to technology being developed in Israel.
Mike was the President of the Boston Scientific Corporation Cardiology business from 1995 to 2000 and is a co-founder of eight medical technology companies including Velocimed, LLC, a former RiverVest Fund I portfolio company acquired by St. Jude Medical, Inc. In addition, he was a founding director of Lutonix, Inc., a former RiverVest Fund II portfolio company acquired by C.R. Bard, Inc. He currently serves as a board member of a number of private and public medical technology companies.
Mike earned an M.B.A. and a B.S. from Cornell University.
Personal Interests: running, mountain biking and skiing
Committed to Doing Business the Right Way to Deliver the Best Outcomes for Patients, Entrepreneurs, and Investors
St. Louis, San Diego & Cleveland
Our Team
A Strong Partnership Built to Last

SchmelterCo-Founder & Managing Director

McKearnManaging Director

O'DonnellManaging Director

MelzerCo-Founder and Managing Director

HongManaging Director

RappManaging Director

SpilizewskiVice President

WeitzmanChief Financial Officer

CatheyDirector of Administration

ZikePrincipal

KroteeSenior Associate

BermanConsultant and Venture Partner

RotherDirector of Finance

HarrisController

KleiboekerAnalyst

SeitzAnalyst

KellerConsultant

ShortExecutive Assistant
Our Team
Scientific Advisors

BorchardtDistinguished Professor Emeritus, The University of Kansas-Lawrence

DiPersioChief, Division of Oncology and Deputy Director, Siteman Cancer Center, Washington University School of Medicine

RaderProfessor, UF Scripps Biomedical Research

RutterProfessor of Biochemistry and HHMI Investigator, University of Utah

SetteProfessor and Member LaJolla Institute for Immunology, Division of Vaccine Discovery Center for Infectious Disease and Vaccine Research

TontonozFrancis and Albert Piansky Professor of Pathology, Professor of Biological Chemistry, University of California, Los Angeles
15 Companies Founded
Collaborative Approach and Open Communication
An exceptional firm culture where each is expected to be transparent, strategic, dependable, results-driven, collaborative, and grounded in purpose. That's RiverVest.